https://www.selleckchem.com/pr....oducts/cid44216842.h
013 and p=0.04, respectively). CONCLUSION MMR-deficient high-grade endometrioid tumors might be more likely to benefit from immunotherapy compared to other grade 3 endometrial carcinomas. BACKGROUND/AIM Treatment of elderly patients with cancer has increasing importance. Since many of these patients may not tolerate standard treatments, they might benefit from personalized approaches. This study was performed to identify characteristics that allow estimation of survival in elderly patients with prostate cancer with cerebral metastas
Like
Comment
Share
